My cholesterol came back high

And the number everyone worries about was never actually measured.

It usually arrives as a text or via a link from the NHS app. Your recent blood test results are available. You may well get a note asking you to book an appointment. "Book an appointment?" you mouth, and think, god, what did they find? Or more likely there will be a link taking you to the app. Scrolling down, you will see each line with a normal range listed, then a scale, yellow, green, yellow, and an arrow showing whether you have made it into the green or landed either side of the sweet spot.
A link to "What is a cholesterol test?". A link to "View your history". And then nothing. You have a number, you have a colour showing where you landed, and the decision to call in if you want to know more. I am not knocking the NHS. Far from it, the NHS is priceless. Those of you who have read previous blogs know that both my mum and dad were treated by the NHS while they were over visiting me. The NHS is remarkable. I have been lucky enough to travel to a lot of countries and I have always come back amazed at what we have here in England. I say England, because I recently found out that our friends in Scotland do not have the app or access to their previous results, though I am aware they are now rolling out their own. So we are getting somewhere. But the sheer number of tests, results and follow ups has to be managed this way. There are not enough hands on phones to give every person their results and talk through what it all means.
So let me shed some light on what that result actually tells you, and the three things on it that most people have never had explained.
First, what cholesterol is for
Cholesterol has spent forty years being talked about as though it were a villain, something to avoid at all costs. It is far from the bad guy. It is one of the foundational building blocks of the human body.
It makes up the walls of every single cell you have, and it is the thing that keeps those walls flexible rather than rigid. It is the raw material your body builds its steroid hormones from, including testosterone, oestrogen and cortisol. It is the starting point for vitamin D. And it makes the bile acids you need in order to digest fat at all.
You would not survive a week without it. Your liver makes most of it precisely because it is too important to leave to what you eat.
Here is something fascinating. Most of the cholesterol in your gut didn't come from your dinner. Your bile delivers between 800 and 1,200mg into your intestine every day, and a typical diet brings 300 to 500mg. So, most of what your gut absorbs is cholesterol your own liver put there. How much you take up is capped. It varies between people, and those who absorb more tend to make less.
So the question is never whether you have cholesterol, it's how much of it is being carried around in the particles that cause problems.
What is actually on your result

A standard UK lipid profile gives you total cholesterol, HDL, LDL, non-HDL and triglycerides, usually with a total to HDL ratio.
Here is the part I want to make you aware of. Your LDL was not measured, It was calculated, from the other three.
For decades the standard method has been something called the Friedewald equation, which takes your total cholesterol, subtracts your HDL, and then subtracts an estimate of the cholesterol sitting in another particle, worked out by dividing your triglycerides by 2.2. Non-HDL is simpler, it's just your total minus your HDL.
Note - Triglycerides are blood fats used for energy. Your body creates them from unused calories, especially sugar and carbs, and stores them in fat cells to burn between meals.
Which means that if your result shows total cholesterol, LDL and non-HDL all flagged as raised, you may be looking at one piece of information written out three times. Three red crosses on a page are far more alarming than one, but it is the same finding.
Why that matters, and it is not a conspiracy
The Friedewald equation is not a trick. It is a reasonable estimate that has served medicine well for fifty years, and the alternative is not obviously better. Measuring LDL directly is more expensive, different laboratories do not do it the same way, and when it is checked against the best available method it reads consistently off, by enough to change what a clinician would recommend. That is why UK guidance does not recommend it for general use.
But the estimate has limits, and the people who wrote the UK guidance say so. It assumes a fixed relationship between triglycerides and another lipid particle. It needs a fasting sample. This part matters, because almost nobody is told to fast. Current UK guidance does not require it, and the guidance knows this is a compromise. If non-fasting triglycerides come back above 4.5 mmol/L, it says to repeat the test fasting, which is, I think, an acknowledgement that the calculation stops working. It also becomes inaccurate when LDL is low.
And it has limited use when triglycerides are raised, which they note is an increasingly common problem as obesity and diabetes-related dyslipidaemia become more prevalent.
See the note above on triglycerides to connect the dots, and read that last sentence again. The calculation struggles in exactly the people most likely to be sitting in front of a doctor about their cholesterol.
UK laboratories are now being encouraged to move to a better equation, the Sampson-NIH, which handles raised triglycerides and works on a non-fasting sample. It is still a calculation, it's just a accurate one.
The part the internet has got backwards
If you have spent any time on health podcasts this year, you will have heard that LDL is finished, that it was never the right marker, and that ApoB is the only thing that matters. A new cholesterol guideline was published in March, replacing the one that had stood since 2018, written by eleven American heart and cardiology organisations. And it brought LDL targets back.
Under 2.6 mmol/L for people at borderline or intermediate risk. Under 1.8 mmol/L at high risk. Under 1.4 mmol/L for those at very high risk after a cardiac event. Treatment goals had been quietly dropped from the previous version and they are now explicitly back, with the authors describing lower for longer as the principle.
Note. The guideline is American and states these as under 100, 70 and 55 mg/dL. I have converted them to the units on your UK result.
ApoB, which counts the number of harmful particles rather than the cholesterol inside them, is in the guideline. But it is recommended selectively, to assess what risk is left over in specific groups, people with diabetes, with metabolic and kidney conditions, with raised triglycerides or established heart disease, and particularly once they have already reached their LDL goals. It is a second test for a specific question, not a replacement for the first one.
I am saying this as somebody who thinks ApoB is genuinely useful. The UK joint statement on lipid testing makes the case for it in a single sentence: despite apparent optimal lowering of calculated LDL, cardiovascular events still happen frequently. That is a real problem and ApoB helps with it.
But "LDL is dead" is not what the evidence said. It is what the internet said about what the evidence said, and those have not been the same thing this past year.
The little thing that is not on your result at all

Lipoprotein(a). Usually written Lp(a) and said out loud as L-P-little-a.
It is a cholesterol carrying particle with an extra protein stuck to it, and that extra protein makes it stickier and more inclined to lodge in an artery wall and to encourage clotting. Think of it as an LDL particle carrying one of those claw grabbers you use to pick up rubbish.
How much of it you make is decided almost entirely by your genes. Diet, exercise and losing weight barely touch it. Which has one very practical consequence, and it is why the guidelines say you only need the test once in your lifetime.
Note. Diet, exercise and losing weight are important areas to focus on for long term health. In this context I am talking specifically about what will move Lp(a).
Where the UK actually stands on it
Hold up, this part is worth reading before you ring your surgery.
In March, the new American guideline recommended that every adult have Lp(a) measured once in their lifetime.
The National Institute for Health and Care Excellence, NICE, does not mention it. The current NICE guideline on cardiovascular risk and lipid modification, NG238, was published in December 2023 and replaced the one before it. Lp(a) does not appear in it. Not as a recommendation, not as a consideration, not once.
HEART UK, the national cholesterol charity, published a call to action a few months before that guideline came out, noting that there were then no Lp(a) recommendations in any UK guideline and asking for it to be added. Unfortunately, it was not.
What HEART UK does recommend is targeted testing. They advise measuring it if you have a personal or family history of early cardiovascular disease, if you have familial hypercholesterolaemia, if a close relative has a raised Lp(a), or if you have calcium build-up on your aortic valve. They have said explicitly that they do not currently advocate screening the whole population.
A national survey of UK laboratories found that 3 out of 60 had adopted the HEART UK recommendations in full. When lipid clinics were asked what stopped them testing, the answers were cost and the absence of national guidance.
So if any of those groups describe you, there is a UK consensus behind asking, and it is reasonable to take that to your GP. If none of them does, you are currently looking at a private test, and it is worth knowing that before you go rather than finding out at the clinic.
And the thing no number on that page can tell you - Your risk.
A cholesterol result is one input. Risk is calculated from your age, your blood pressure, whether you smoke, whether you have diabetes, your family history and more besides. In the UK that is done with a tool called QRISK3, and NICE recommends it for everybody between 25 and 84 who does not already have cardiovascular disease.
This is why two people can walk out with the same LDL and two entirely different conversations ahead of them. And why a single flagged number, read on its own, in an app, is almost impossible to interpret sensibly.
Three things you can actually do
One. Find out whether you are in one of those groups, and if you are, ask about Lp(a). And if yours comes back raised, that is genetic rather than anything you have done, which means it may be relevant to your relatives too. That is not an easy conversation to open. It is worth thinking about who in your family would actually want to know, rather than feeling you have to tell everyone.
You may remember Chris Hemsworth going public with a genetic result a few years ago. Different gene, different condition, but the useful part was how he reflected on the results. He described the result as not pre-deterministic, and a fair amount of the coverage still reported it as a diagnosis.
A raised Lp(a) belongs in the same category. It tells you something about probability. It does not tell you what is going to happen.
Two. Get fitter. In the Copenhagen Male Study, 5,107 men were followed for 46 years. The fittest 5% lived 4.9 years longer than the least fit. Fitness is not the only thing on this list, but it is the one with the largest effect and it is entirely in your control.
Three. Eat more fibre. Meta-analyses of prospective studies put it at roughly 9% lower cardiovascular risk for every extra 10g a day. Beans, lentils, oats, fruit, vegetables, nuts. Most adults in the UK are eating around two thirds of the recommended amount, so there is room for more of nature's own.
Where I would send you somewhere else
If you have chest tightness or pain when you exert yourself, breathlessness that is new, or pain spreading into your jaw or arm, that is not a nutrition conversation and it is not a next week conversation. That is medical, today. And if the pain is severe, comes with sweating or nausea, or does not settle, that is 999 call.
And if anyone in your immediate family had a heart attack or stroke before 60, say so out loud at your appointment. It changes how your result should be read and it is the single most useful thing you can tell your GP.
What I take from all this
Your cholesterol result is not a verdict but it is not nothing either. It is a partial picture, with one number calculated rather than measured, one number missing entirely, and no risk attached to any of it.
That is not a reason to dismiss it, it's a reason to get the rest of the picture before you decide how worried to be.
That is the work I do. The UK joint statement on lipid testing describes something called an enhanced lipid profile, which adds ApoB and Lp(a) to the standard panel, and arranging that and reading it in the context of your life, your training, your family history and what you actually eat is my territory. Where something needs a prescription, that is your GP, and with your consent I will work with them.
Better is available. Time to Lean in, Learn and Level up.
References:
Kenkre JS, Mazaheri T, Neely RDG, et al. Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine. Annals of Clinical Biochemistry2025;62(4):257–286. doi:10.1177/00045632251315303
Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. JACC 2026. doi:10.1016/j.jacc.2025.11.016
National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline NG238. Published 14 December 2023.
NHS England. Summary of national guidance for lipid management for primary and secondary prevention of cardiovascular disease.
HEART UK Lipoprotein(a) Taskforce. A Call to Action. August 2023.
Cegla J, Neely RDG, France M, et al. HEART UK consensus statement on Lipoprotein(a): A call to action. Atherosclerosis 2019.
Ansari S, Neely RDG, Payne J, Cegla J. The current status of lipoprotein(a) measurement in clinical biochemistry laboratories in the UK: results of a 2021 national survey. Annals of Clinical Biochemistry 2024.
Clausen JSR, Marott JL, Holtermann A, Gyntelberg F, Jensen MT. Midlife cardiorespiratory fitness and the long-term risk of mortality: 46 years of follow-up. Journal of the American College of Cardiology 2018;72(9):987–995. doi:10.1016/j.jacc.2018.06.045
Turley SD, Dietschy JM. The intestinal absorption of biliary and dietary cholesterol as a drug target for lowering the plasma cholesterol level. Preventive Cardiology 2003.
NHS Genomics Education Programme. Marvel star goes public on his APOE genetic link to Alzheimer's.https://www.genomicseducation.hee.nhs.uk/blog/marvel-star-goes-public-on-his-apoe-genetic-link-to-alzheimers/





Comments